2011
DOI: 10.1136/jmg.2010.085456
|View full text |Cite
|
Sign up to set email alerts
|

Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3

Abstract: Background-Mutations of UNC13D are causative for familial haemophagocytic lymphohistiocytosis type 3 (FHL3; OMIM 608898).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
55
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(62 citation statements)
references
References 40 publications
6
55
1
Order By: Relevance
“…Interestingly, patients with FHL2 and patients with FHL3 with missense mutations have a significantly later onset of disease than patients with nonsense mutations. [34][35][36] As has been described for patients with FHL5 before, our patients also displayed a large spectrum of features that are not part of the typical HLH clinical picture. 26,27 Previous studies have reported an ubiquitous Munc18-2 RNA expression not restricted to hematopoietic cells, suggesting a role of the protein in vesicle transport in many mammalian tissues.…”
Section: Genetic and Clinical Spectrum Of Fhl5 Patients 6021supporting
confidence: 72%
“…Interestingly, patients with FHL2 and patients with FHL3 with missense mutations have a significantly later onset of disease than patients with nonsense mutations. [34][35][36] As has been described for patients with FHL5 before, our patients also displayed a large spectrum of features that are not part of the typical HLH clinical picture. 26,27 Previous studies have reported an ubiquitous Munc18-2 RNA expression not restricted to hematopoietic cells, suggesting a role of the protein in vesicle transport in many mammalian tissues.…”
Section: Genetic and Clinical Spectrum Of Fhl5 Patients 6021supporting
confidence: 72%
“…By comparison, the age at diagnosis is similar to patients with 2 disruptive mutations in UNC13D (3 months). 39 Thus, although a slight improvement in degranulation and cytotoxicity was seen in the patients carrying the inversion, no difference was seen in terms of age at onset in this group of patients compared with other FHL3 patients.…”
Section: Clinical Characteristics Neurologic Manifestations and Outmentioning
confidence: 56%
“…45 In both cohorts, we observed previously that the nature of the mutation, disruptive or missense, could explain a certain heterogeneity of residual degranulation, as described for FHL3 patients. 46 In contrast, resting NK-cell degranulation was above 5% in 29 of 30 patients (97%) with FHL2 or with 1 of the 2 XLP variants and in 58 of 59 patients (98%) with secondary HLH. Therefore, as suggested previously in smaller studies, 29,30,37,42 the assay clearly discriminated between patients with genetic disorders predisposing to HLH that are associated with impaired degranulation and those that are not.…”
Section: Discussionmentioning
confidence: 91%